Friday, November 17, 2023
Print Current Session:
![]() |
|
Friday
SESSION 83:
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
Location: Grand Ballroom East, 3rd Floor
Moderators:Christopher J. Kwolek, MD, MBA / Anne L. Abbott, MD, PhD, FRACP |
|
SESSION 83 SCHEDULE | |
1:00 PM - 1:05 PM | Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
UPDATE ON CAROTID RCTs | |
1:06 PM - 1:11 PM | 5-Year Results From SPACE 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For ACS: These Results Support A More Conservative Approach To ACS: What More Is Needed |
Presenter(s):Hans-Henning Eckstein, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
1:12 PM - 1:17 PM | DEBATE: Update On ACST 2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates And Implied That Both Invasive Treatments Were Superior To BMT: Does CEA Prevent Dementia |
Presenter(s):Alison Halliday, MS, FRCS / Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
1:18 PM - 1:23 PM | DEBATE: Not So Fast! ACST 2 – Like CREST – Has Flaws That Invalidate Their Conclusions: Invasive Therapies May NOT Be Better Than BMT |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
1:24 PM - 1:30 PM | Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Recruitment And Findings To Date: Why Not Present The 30-Day And 1 Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS or CEA, Wouldn’t It Remove Justification For Invasive Treatment Of ACS |
Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
1:30 PM - 1:35 PM | CEA Versus CAS For High-Grade ACS: RCTs (ACT 1 And CREST) Analyzed By Age And Sex: Are There Important Differences |
Presenter(s):Jon S. Matsumura, MD Location: Grand Ballroom East, 3rd Floor |
|
TANDEM CAROTID LESIONS | |
1:36 PM - 1:41 PM | DEBATE: Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid |
Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc Location: Grand Ballroom East, 3rd Floor |
|
1:42 PM - 1:47 PM | DEBATE: Tandem Carotid Lesions: Treatment Risks Need NOT Be Increased: Based On A Meta-Analysis: How Best To Treat To Minimize Risk |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
1:48 PM - 1:53 PM | Silent Coronary Ischemia As Detected By FFRCT Is Common In Carotid Stenosis Patients: Coronary Revascularization In Such Patients Decreases Mortality: When Should It Be Done – Before Or After Carotid Treatment |
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
1:54 PM - 2:02 PM | Panel Discussion |
END OF SESSION 83 | |
previous | next |